Skip to the content
  • Our Company
    • Leadership
    • Board of Directors
  • Science & Innovation
    • Our Approach
    • Our Pipeline
  • Culture
  • Media
    • Resources
    • News
  • News
  • Contact
Menu
  • Our Company
    • Leadership
    • Board of Directors
  • Science & Innovation
    • Our Approach
    • Our Pipeline
  • Culture
  • Media
    • Resources
    • News
  • News
  • Contact

Lighting the Way to Breakthrough Medicines

Delivering on the Promise of Oral Peptides

At Nimble, we're pioneering the development of oral therapies for immune-mediated diseases that mirror the effects of well-established treatments. By harnessing the power of our proven discovery engine, we're accelerating the advancement of our emerging pipeline into clinical trials.

Our Approach
Our Pipeline

PRE-HEADER

Lorem Ipsum Dolor 
Sit Amet Consectetur Adipiscing

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vivamus sollicitudin purus non ex finibus tincidunt. Pellentesque blandit sapien sed urna convallis vehicula.
Call to Action

PIPELINE WITH PROMISE

Our Platform Accelerates The Discovery Of Oral Therapies

See Our Pipeline

Recent News

News

Nimble Therapeutics Adds Peptide Drug Development Expertise to Board of Directors

Read News
News

Nimble Therapeutics named a 2023 Best Place to Work by Madison Magazine

Read News

More To Read

News
  • March 20, 2024

Nimble Therapeutics Adds Peptide Drug Development Expertise to Board of Directors

Read News
News
  • March 13, 2024

Nimble Therapeutics named a 2023 Best Place to Work by Madison Magazine

Read News
News
  • January 5, 2023

Nimble Therapeutics Announces Expansion of its Discovery and Development Partnership with Genentech

Read News
View All News
  • Our Team
  • Our Pipeline
  • Partner
  • Resources
  • News
  • Careers
  • Contact
  • Our Team
  • Our Pipeline
  • Partner
  • Resources
  • News
  • Careers
  • Contact
  • CONNECT ON LINKEDIN

Copyright © 2024 Nimble Therapeutics, Inc